Journal of Metabolic Medicine, 12 (6), 512523
Discontinue IMCIVREE when pregnancy is recognized unless the benefits of therapy outweigh the potential risks to the fetus
These findings suggest that GLP-1RAs may have therapeutic potential beyond diabetes and obesity, particularly in the treatment of addictions to palatable foods, alcohol, and drugs
Medication options for weight management The tools these programs reach for are the GLP-1 receptor agonists and the GIP/GLP-1 dual agonist tirzepatide
Malaguarnera M, Restuccia S, Di Fazio I, et al
Judge Marston has implemented standardized filing procedures, including short-form complaints that allow new plaintiffs to efficiently join the litigation while maintaining individual damage claims